Attached files

file filename
EX-99.2 - EX-99.2 - Zymeworks Inc.d527862dex992.htm
EX-99.1 - EX-99.1 - Zymeworks Inc.d527862dex991.htm




Washington, D.C. 20549







Pursuant to Rule 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 16, 2018



Zymeworks Inc.

(Exact name of registrant as specified in its charter)




British Columbia, Canada   001-38068   47-2569713

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)

Suite 540, 1385 West 8th Avenue, Vancouver, British Columbia, Canada   V6H 3V9
(Address of principal executive offices)   (Zip Code)

(604) 678-1388

(Registrant’s telephone number, including area code)

Not Applicable

(Former name of former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☒





On May 16, 2018, Zymeworks Inc. (“Zymeworks”), a corporation governed by the Business Corporations Act (British Columbia) (the “Act”), filed in Canada on the System for Electronic Document Analysis and Retrieval (“SEDAR”), in compliance with the Act, a management proxy circular in respect of its annual and special shareholders’ meeting. A copy of Zymeworks’ management proxy circular and form of proxy are furnished as Exhibit 99.1 and 99.2 hereto, respectively, and are incorporated herein by reference.

The information provided under this Item (including Exhibits 99.1 and 99.2, attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.



(d) Exhibits


Exhibit No.



99.1    Notice of Annual Meeting of Shareholders and Management Proxy Circular of Zymeworks Inc., filed on SEDAR on May 16, 2018.
99.2    Form of Proxy of Zymeworks Inc., filed on SEDAR on May 16, 2018.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.




Date: May 16, 2018   By:  

/s/ Neil Klompas





Neil Klompas

Chief Financial Officer